To prescribe buprenorphine, one of three medications approved by the FDA for the treatment of opioid use disorder, physicians are required to complete 8 hours of training in order to apply to the Drug Enforcement Agency for a waiver. This free course will provide prescribers with the 8 hours of required MAT training. Following completion of the course, attendees will be given a link to complete the remainder of the training at no cost from the Providers Clinical Support System (PCSS). Nurse Practitioners (NP) and Physician assistants (PA) are required to complete 24 hours of training including the 8 hour MAT training.

Registration: Free

At the conclusion of this activity participants should be able to:
• Review addiction treatment in office-based practices
• Discuss the pharmacological treatments of opioid use disorder
• Determine what medical record documentation must be followed
• Discuss the process of buprenorphine induction as well as stabilization and maintenance techniques
• Describe how to take a patient history and evaluation
• Review safety concerns and drug interactions

This event has been approved by the Office of Continuing Medical Education and has been awarded a maximum of 8 AMA PRA Category 1 Credit(s). Please contact cabhp@asu.edu with any questions.

Accreditation and Continuing Education Information

American Academy of Addiction Psychiatry is the Data Sponsor for this training. Funding for this course was made possible (in part) by 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government

Additional Funding Attribution: Arizona State Opioid Response (SOR) grant, Arizona Health Care Cost Containment System, Substance Abuse and Mental Health Services Administration, grant #T1081709-01.